A two-year human trial conducted by James Cook University (JCU) has concluded, demonstrating positive results using low-dose human hookworm therapy to treat chronic conditions, particularly in relation to type 2 diabetes. New Atlas reports: [O]f the 24 participants who received worms, when offered a dewormer at the end of the second year of the trial, with the option to stay in the study for another 12 months, only one person chose to kill off their gut buddies — and it was only because they had an impending planned medical procedure. “All trial participants had risk factors for developing cardiovascular disease and type 2 diabetes,” said Dr Doris Pierce, from JCU’s Australian Institute of Tropical Health and Medicine (AITHM). “The trial delivered some considerable metabolic benefits to the hookworm-treated recipients, particularly those infected with 20 larvae.”

In this double-blinded trial, 40 participants aged 27 to 50, with early signs of metabolic diseases, took part. They received either 20 or 40 microscopic larvae of the human hookworm species Necator americanus; another group took a placebo. As an intestinal parasite, the best survival skill is to keep the host healthy, which will provide a long-term stable home with nutrients ‘on tap.’ In return, these hookworms pay the rent in the form of creating an environment that suppresses inflammation and other adverse conditions that can upset that stable home. While the small, round worms can live for a decade, they don’t multiply unless outside the body, and good hygiene means transmission risk is very low.

As for the results, those with 20 hookworms saw a Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) level drop from 3.0 units to 1.8 units within the first year, which restored their insulin resistance to a healthy range. The cohort with 40 hookworms still experienced a drop, from 2.4 to 2.0. Those who received the placebo saw their HOMA-IR levels increase from 2.2 to 2.9 during the same time frame. “These lowered HOMA-IR values indicated that people were experiencing considerable improvements in insulin sensitivity — results that were both clinically and statistically significant,” said Dr Pierce. Those with worms also had higher levels of cytokines, which play a vital role in triggering immune responses. The study was published in the journal Nature Communications.

Source: Hookworms Successfully Prevent Type 2 Diabetes In Human Trial – Slashdot

Once tooth decay has set in, all a dentist can do is fill the gap with an artificial plug — a filling. But in a paper published in Cell, Hannele Ruohola-Baker, a stem-cell biologist at the University of Washington, and her colleagues offer a possible alternative. Economist: Stem cells are those that have the capacity to turn themselves into any other type of cell in the body. It may soon be possible, the researchers argue, to use those protean cells to regrow a tooth’s enamel naturally. The first step was to work out exactly how enamel is produced. That is tricky, because enamel-making cells, known as ameloblasts, disappear soon after a person’s adult teeth have finished growing. To get round that problem, the researchers turned to samples of tissue from human foetuses that had been aborted, either medically or naturally. Such tissues contain plenty of functioning ameloblasts. The researchers then checked to see which genes were especially active in the enamel-producing cells. Tooth enamel is made mostly of calcium phosphate, and genes that code for proteins designed to bind to calcium were particularly busy. They also assessed another type of cell called odontoblasts. These express genes that produce dentine, another type of hard tissue that lies beneath the outer enamel. Armed with that information, Dr Ruohola-Baker and her colleagues next checked to see whether the stem cells could be persuaded to transform into ameloblasts.

The team devised a cocktail of drugs designed to activate the genes that they knew were expressed in functioning ameloblasts. That did the trick, with the engineered ameloblasts turning out the same proteins as the natural sort. A different cocktail pushed the stem cells to become odontoblasts instead. Culturing the cells together produced what researchers call an organoid — a glob of tissue in a petri dish which mimics a biological organ. The organoids happily churned out the chemical components of enamel. Having both cell types seemed to be crucial: when odontoblasts were present alongside ameloblasts, genes coding for enamel proteins were more strongly expressed than with ameloblasts alone. For now, the work is more a proof of concept than a prototype of an imminent medical treatment. The next step, says Dr Ruohola-Baker, is to try to boost enamel production even further, with a view to eventually beginning clinical trials. The hope is that, one day, medical versions of the team’s organoids could be used as biological implants, to regenerate a patient’s decayed teeth.

Source: Scientists Want To Fix Tooth Decay With Stem Cells – Slashdot